CRL
Charles River Laboratories International, Inc.
stockNYSE
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 339.66 | 2026-10-22 | +10.72% | 0.653 |
| 1M | 295.96 | 2026-09-29 | +27.06% | 2.321 |
| 3M | 234.80 | 2026-07-29 | +60.16% | 0.993 |
| 6M | 163.84 | 2026-04-29 | +129.53% | 0.854 |
| 1Y | 180.15 | 2025-10-29 | +108.75% | 1.282 |
| 2Y | 184.00 | 2024-10-29 | +104.38% | — |
| 5Y | 448.68 | 2021-10-29 | -16.18% | 1.269 |
Charles River Laboratories International, Inc. (NYSE:CRL) stock price today is $376.06, and today's volume is 645,668. CRL is up 0.556% today. The 30 day average volume is 1.13M. CRL market cap is $17.95B with 47.74M shares outstanding.